Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01155414 · ClinicalTrials.gov registry record · Phase 3

Tolerance of Healthy Term Infants Fed Infant Formulas #4

A Phase 3 study, sponsored by Abbott Nutrition.

Completed
Registry status
Phase 3
Development phase
168
Enrollment target

NCT01155414: Completed Phase 3 study, sponsored by Abbott Nutrition.

NCT01155414 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 168 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01155414, a Phase 3 study, has completed, sponsored by Abbott Nutrition.

COMPLETED
Registry status
Phase 3
Development phase
168 participants
Enrollment target

Study Summary

The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.

Interventions

  • OTHER Hydrolysate based infant formula
  • OTHER Investigational Infant Formula A
  • OTHER Investigational Infant Formula B

Trial Details

FieldValue
Enrollment Target 168 participants
Start Date 2010-03
Est. Completion 2010-07
Phase Phase 3
Abbott Nutrition

89 total trials

What the finished NCT01155414 record still lists

NCT01155414 is an interventional study that assigns participants to a tested intervention. The registered 168 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (78% lower).

The record links to 0 conditions, and to 3 interventions - of which Hydrolysate based infant formula is the first listed.

NCT01155414 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01155414 about?

NCT01155414 is a clinical study titled "Tolerance of Healthy Term Infants Fed Infant Formulas #4". The primary objective of this study is to assess the comparative gastrointestinal (GI) tolerance of normal term infants to two experimental powdered formulas compared with a commercially available powdered formula.

What is the current status of trial NCT01155414?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 2010-03. Estimated completion is 2010-07.

What interventions are being tested in trial NCT01155414?

The interventions under investigation include: Hydrolysate based infant formula (OTHER), Investigational Infant Formula A (OTHER), Investigational Infant Formula B (OTHER).

Who is sponsoring clinical trial NCT01155414?

This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01155414's enrollment target sits among peer trials

168 1459th of 2000 higher than 538 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02118922 · 168 participants

    A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia

  • NCT03536897 · 168 participants

    IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry

  • NCT04078230 · 168 participants · NA

    Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma

  • NCT04159168 · 168 participants · NA

    Facial Affect Sensitivity Training for Young Children With Callous-unemotional Traits

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01155414, the US trial registry maintained by the National Library of Medicine. NCT01155414 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.